posted on Jun, 2 2014 @ 08:33 PM
Dichloroacetate (DCA) is a small molecule drug that has long been used to treat congenital mitochondrial abnormalities. The mitochondria (cell power
source), is vital for several reasons. One of them is acting as oxygen sensors and control, as well as controlling programmed cell death. This process
is known as apoptosis. The significance here is that this process is suppressed in cancer, a disease that’s characterized by uncontrolled cell
growth. Dr. Evengelos Michelakis, associate chair and medical researcher at the University of Alberta’s faculty of medicine and his team of
researchers discovered DCA as a possible cure for cancer more than 10 years ago. Since then, it’s received very little attention from the medical
ONE clinical trial (finally) is under way, and the estimated date for completion is March 2015. You can read more about the clinical trial details
Medicor Cancer Centres in Canada have been using this for some time medicorcancer.com...